Review




Structured Review

Ferring Pharmaceuticals computer-generated randomisation code
Computer Generated Randomisation Code, supplied by Ferring Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation/pmc11422753-1997-29-6
Average 90 stars, based on 1 article reviews
computer-generated randomisation code - by Bioz Stars, 2026-09
90/100 stars

Images

Related Articles

Sequencing:

Article Title: Carbetocin for preventing postpartum haemorrhage
Article Snippet: .. Notes The project was supported by Ferring Pharmaceuticals Ltd. Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Method of randomisation: computer‐generated randomisation code. ..

Selection:

Article Title: Carbetocin for preventing postpartum haemorrhage
Article Snippet: .. Notes The project was supported by Ferring Pharmaceuticals Ltd. Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Method of randomisation: computer‐generated randomisation code. ..

Article Title: Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI)
Article Snippet: Dose-adjustment was not permitted in the individualised dosing arm Outcomes Reported in paper: live birth, ongoing pregnancy, clinical pregnancy, number of oocytes, total dose of FSH, duration of FSH, multiple pregnancy, moderate and severe OHSS, had at least 1 transferable embryo, normal response to stimulation Obtained from author correspondence*: cycle cancellations for poor and hyper-response Not available: severe OHSS, poor response, hyper-response (this data was available only in participant subgroups, and authors declined to provide the non-stratified data) Notes Trial registration: NCT01956110, prospectively Funding: Ferring Pharmaceuticals Conflict of interest: many investigators have received grants or are employed by Industry Presented in part at the 32nd Annual Meeting of the European Society of Human Reproduction and Embryology, July 3-6, 2016, Helsinki, Finland Email correspondence undertaken: yes with Ferring staff; however, not all requested information was provided (Helmgaard 2017b [pers comm]) *indicates information obtained from email correspondence Risk of bias Bias Authors’ judgement Support for judgement Random sequence generation (selection bias) Low risk Paper states “Women were randomly assigned in a 1:1 ratio via a central computer-generated randomization sequence, prepared by an independent statistician. .. Randomization was stratified by age (< 35, 35-37, and 38-40 years) and performed in blocks of four within trial sites.” Allocation concealment (selection bias) Low risk No description in the paper; however, correspondence with Ferring reveals that the randomisation allocation was concealed within the computer programme until the time of randomisation. ..

Article Title: Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI)
Article Snippet: Random sequence generation (selection bias) , Low risk , Paper states "Women were randomly assigned in a 1:1 ratio via a central computer‐generated randomization sequence, prepared by an independent statistician. Randomization was stratified by age (< 35, 35–37, and 38–40 years) and performed in blocks of four within trial sites.". .. Allocation concealment (selection bias) , Low risk , No description in the paper; however, correspondence with Ferring reveals that the randomisation allocation was concealed within the computer programme until the time of randomisation. The unblinded study nurse managed the randomisation as the other investigators were unaware of the trial allocations*. ..

Article Title: Oxytocin receptor antagonists for inhibiting preterm labour
Article Snippet: Random sequence generation (selection bias) , Low risk , "Computer‐generated randomisation lists for each center was used to allocate women to study treatment and women were stratified by gestational age at enrolment." The review authors consider this approach low risk.. .. Allocation concealment (selection bias) , Low risk , Prepared by Ferring Pharmaceuticals: computer‐generated randomisation stratified by GA and centre, supplied to pharmacists at each centre in pre‐randomised boxes labelled with country code and case number.. ..

Article Title: Oxytocin receptor antagonists for inhibiting preterm labour
Article Snippet: .. Allocation concealment (selection bias) Low risk Prepared by Ferring Pharmaceuticals: computer‐generated randomisation stratified by GA and centre, supplied to pharmacists at each centre in pre‐randomised boxes labelled with country code and case number. ..

other:

Article Title: Tocolytics for delaying preterm birth: a network meta-analysis (0924)
Article Snippet: No COI Funded by Ferring Pharmaceuticals Risk of bias Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Randomised using computer-generated randomisation lists and stratified by GA (≤ 28 weeks and > 28 weeks) Allocation concealment (selection bias) Unclear risk NR Blinding of participants and personnel (performance bias) All outcomes Low risk Double-blind.

Article Title: Oxytocin receptor antagonists for inhibiting preterm labour
Article Snippet: Published by John Wiley & Sons, Ltd. European 2001 (Continued) Allocation concealment (selection bias) Low risk Prepared by Ferring Pharmaceuticals: computer-generated randomisation stratified by GA and centre, supplied to pharmacists at each centre in pre-randomised boxes labelled with country code and case number Blinding of participants and personnel (performance bias) All outcomes Low risk “Through the use of a double-blind, double-dummy technique, the utmost effort was made to keep the study blinded.

Article Title: Oxytocin receptor antagonists for inhibiting preterm labour
Article Snippet: Allocation concealment (selection bias) Low risk Prepared by Ferring Pharmaceuticals: computer-generated randomisation stratified by GA and centre, supplied to pharmacists at each centre in pre-randomised boxes labelled with country code and case number Blinding of participants and personnel (performance bias) All outcomes Low risk “Through the use of a double-blind, double-dummy technique, the utmost effort was made to keep the study blinded.



Similar Products

90
Cipla Inc computer generated randomisation code
Computer Generated Randomisation Code, supplied by Cipla Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation+code/pmc06485805-575-2-18
Average 90 stars, based on 1 article reviews
computer generated randomisation code - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Pfizer Inc computer-generated randomisation codes
Computer Generated Randomisation Codes, supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation+list/pmc06483741-2243-40-10
Average 90 stars, based on 1 article reviews
computer-generated randomisation codes - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Boehringer Ingelheim computer‑generated randomisation code
Bateman 2010a
Computer‑Generated Randomisation Code, supplied by Boehringer Ingelheim, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation+code/pmc08934583-115-16-20
Average 90 stars, based on 1 article reviews
computer‑generated randomisation code - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Boehringer Ingelheim computer-generated randomisation code
Bateman 2010a
Computer Generated Randomisation Code, supplied by Boehringer Ingelheim, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation+code/pmc10879916-322-16-20
Average 90 stars, based on 1 article reviews
computer-generated randomisation code - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Ferring Pharmaceuticals computer-generated randomisation code
Bateman 2010a
Computer Generated Randomisation Code, supplied by Ferring Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation/pmc11422753-1997-29-6
Average 90 stars, based on 1 article reviews
computer-generated randomisation code - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Bayer Schering Pharma computer-generated randomisation codes
Bateman 2010a
Computer Generated Randomisation Codes, supplied by Bayer Schering Pharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation+codes/pm18395326-57-0-7
Average 90 stars, based on 1 article reviews
computer-generated randomisation codes - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Pharmacia Upjohn LLC computer generated randomisation code
Bateman 2010a
Computer Generated Randomisation Code, supplied by Pharmacia Upjohn LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/patches+with+randomization+numbers/pmc01920563-139-7-17
Average 90 stars, based on 1 article reviews
computer generated randomisation code - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Novartis computer-generated randomisation code
Bateman 2010a
Computer Generated Randomisation Code, supplied by Novartis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer%E2%80%91generated+randomisation+code/computer+generated+randomisation+code/pm12765508-76-17-21
Average 90 stars, based on 1 article reviews
computer-generated randomisation code - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Bateman 2010a

Journal: The Cochrane Database of Systematic Reviews

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD009285.pub3

Figure Lengend Snippet: Bateman 2010a

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

Techniques: Medications, Clinical Proteomics, Sequencing, Selection

Bateman 2010b

Journal: The Cochrane Database of Systematic Reviews

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD009285.pub3

Figure Lengend Snippet: Bateman 2010b

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

Techniques: Biomarker Discovery, Sequencing, Selection, Generated, Control

Beeh 2006

Journal: The Cochrane Database of Systematic Reviews

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD009285.pub3

Figure Lengend Snippet: Beeh 2006

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

Techniques: Infection, Medications, Sequencing, Selection, Generated, Control

Brusasco 2003

Journal: The Cochrane Database of Systematic Reviews

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD009285.pub3

Figure Lengend Snippet: Brusasco 2003

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

Techniques: Infection, Medications, Sequencing, Selection, Generated, Control

Casaburi 2002

Journal: The Cochrane Database of Systematic Reviews

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD009285.pub3

Figure Lengend Snippet: Casaburi 2002

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

Techniques: Biomarker Discovery, Sequencing, Selection, Generated, Capsules

Chan 2007

Journal: The Cochrane Database of Systematic Reviews

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD009285.pub3

Figure Lengend Snippet: Chan 2007

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

Techniques: Biomarker Discovery, Infection, Sequencing, Selection, Generated, Control

Cooper 2010

Journal: The Cochrane Database of Systematic Reviews

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD009285.pub3

Figure Lengend Snippet: Cooper 2010

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

Techniques: Biomarker Discovery, Modification, Sequencing, Selection, Generated, Control

Covelli 2005

Journal: The Cochrane Database of Systematic Reviews

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD009285.pub3

Figure Lengend Snippet: Covelli 2005

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

Techniques: Biomarker Discovery, Infection, Sequencing, Selection, Generated, Control

Dusser 2006

Journal: The Cochrane Database of Systematic Reviews

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD009285.pub3

Figure Lengend Snippet: Dusser 2006

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

Techniques: Biomarker Discovery, Infection, Medications, Sequencing, Selection, Generated, Control

Freeman 2007

Journal: The Cochrane Database of Systematic Reviews

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD009285.pub3

Figure Lengend Snippet: Freeman 2007

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

Techniques: Biomarker Discovery, Infection, Sequencing, Selection, Generated

Johansson 2008

Journal: The Cochrane Database of Systematic Reviews

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD009285.pub3

Figure Lengend Snippet: Johansson 2008

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

Techniques: Biomarker Discovery, Infection, Sequencing, Selection, Generated, Control

Magnussen 2008

Journal: The Cochrane Database of Systematic Reviews

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD009285.pub3

Figure Lengend Snippet: Magnussen 2008

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

Techniques: Biomarker Discovery, Sequencing, Selection, Generated, Control

Moita 2008

Journal: The Cochrane Database of Systematic Reviews

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD009285.pub3

Figure Lengend Snippet: Moita 2008

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

Techniques: Biomarker Discovery, Infection, Sequencing, Selection, Generated, Control

NCT00144326

Journal: The Cochrane Database of Systematic Reviews

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD009285.pub3

Figure Lengend Snippet: NCT00144326

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

Techniques: Activity Assay, Plasmid Preparation, Modification, Sequencing, Selection, Generated, Control

Niewoehner 2005

Journal: The Cochrane Database of Systematic Reviews

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD009285.pub3

Figure Lengend Snippet: Niewoehner 2005

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

Techniques: Biomarker Discovery, Medications, Sequencing, Selection, Generated

Powrie 2007

Journal: The Cochrane Database of Systematic Reviews

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD009285.pub3

Figure Lengend Snippet: Powrie 2007

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

Techniques: Biomarker Discovery, Concentration Assay, Sequencing, Selection, Generated, Control

Tashkin 2008

Journal: The Cochrane Database of Systematic Reviews

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD009285.pub3

Figure Lengend Snippet: Tashkin 2008

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

Techniques: Biomarker Discovery, Infection, Medications, Sequencing, Selection, Generated

Tonnel 2008

Journal: The Cochrane Database of Systematic Reviews

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD009285.pub3

Figure Lengend Snippet: Tonnel 2008

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

Techniques: Biomarker Discovery, Infection, Sequencing, Selection, Blocking Assay, Control

Trooster 2011

Journal: The Cochrane Database of Systematic Reviews

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD009285.pub3

Figure Lengend Snippet: Trooster 2011

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

Techniques: Medications, Activity Assay, Sequencing, Selection, Generated, Control

Verkinde 2006

Journal: The Cochrane Database of Systematic Reviews

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD009285.pub3

Figure Lengend Snippet: Verkinde 2006

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

Techniques: Infection, Modification, Sequencing, Selection, Generated, Control

Voshaar 2008

Journal: The Cochrane Database of Systematic Reviews

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease

doi: 10.1002/14651858.CD009285.pub3

Figure Lengend Snippet: Voshaar 2008

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time.

Techniques: Biomarker Discovery, Sequencing, Selection, Generated

Bateman 2010a

Journal: The Cochrane Database of Systematic Reviews

Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

doi: 10.1002/14651858.CD010844.pub2

Figure Lengend Snippet: Bateman 2010a

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

Techniques: Medications, Sequencing, Selection

Brusasco 2003

Journal: The Cochrane Database of Systematic Reviews

Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

doi: 10.1002/14651858.CD010844.pub2

Figure Lengend Snippet: Brusasco 2003

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

Techniques: Infection, Medications, Sequencing, Selection, Generated, Control

Calverley 2007 [TORCH]

Journal: The Cochrane Database of Systematic Reviews

Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

doi: 10.1002/14651858.CD010844.pub2

Figure Lengend Snippet: Calverley 2007 [TORCH]

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

Techniques: Western Blot, Biomarker Discovery, Solvent, Medications, Sequencing, Selection, Generated, Clinical Proteomics

Niewoehner 2005

Journal: The Cochrane Database of Systematic Reviews

Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

doi: 10.1002/14651858.CD010844.pub2

Figure Lengend Snippet: Niewoehner 2005

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

Techniques: Biomarker Discovery, Medications, Sequencing, Selection, Generated, Modification

Ohar 2013

Journal: The Cochrane Database of Systematic Reviews

Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

doi: 10.1002/14651858.CD010844.pub2

Figure Lengend Snippet: Ohar 2013

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

Techniques: Sequencing, Selection

Ozol 2005

Journal: The Cochrane Database of Systematic Reviews

Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

doi: 10.1002/14651858.CD010844.pub2

Figure Lengend Snippet: Ozol 2005

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

Techniques: Sequencing, Selection, Generated

Renkema 1996

Journal: The Cochrane Database of Systematic Reviews

Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

doi: 10.1002/14651858.CD010844.pub2

Figure Lengend Snippet: Renkema 1996

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

Techniques: Biomarker Discovery, Functional Assay, Clinical Proteomics, Sequencing, Selection

Schermer 2009

Journal: The Cochrane Database of Systematic Reviews

Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

doi: 10.1002/14651858.CD010844.pub2

Figure Lengend Snippet: Schermer 2009

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

Techniques: Sequencing, Selection, Generated, Blocking Assay

Tashkin 2008a [UPLIFT]

Journal: The Cochrane Database of Systematic Reviews

Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

doi: 10.1002/14651858.CD010844.pub2

Figure Lengend Snippet: Tashkin 2008a [UPLIFT]

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

Techniques: Biomarker Discovery, Infection, Medications, Sequencing, Selection

Tonnel 2008 [TIPHON]

Journal: The Cochrane Database of Systematic Reviews

Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

doi: 10.1002/14651858.CD010844.pub2

Figure Lengend Snippet: Tonnel 2008 [TIPHON]

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

Techniques: Biomarker Discovery, Infection, Sequencing, Selection, Blocking Assay

Vogelmeier 2011 [POET]

Journal: The Cochrane Database of Systematic Reviews

Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis

doi: 10.1002/14651858.CD010844.pub2

Figure Lengend Snippet: Vogelmeier 2011 [POET]

Article Snippet: Random sequence generation (selection bias) , Low risk , Treatment allocation was determined by a computer‐generated randomisation code provided by Boehringer Ingelheim. Randomisation was stratified by study centre and within centres, and performed in blocks to ensure balanced distribution of the treatment groups at any time..

Techniques: Biomarker Discovery, Infection, Medications, Sequencing, Selection, Generated, Blocking Assay, Capsules